Table 5

Prevalence and intensity of symptoms at inclusion into the study and follow-up 48–72 h postintervention

SymptomN%NRS* basal visitNRS follow-up visit 48–72 hNRS≤4 follow-up visit 48–72 h %*NRS % reduction†
MeanSDMeanSDMeanSDp Value‡
Pain24667.66.02.03.02.076.754.633.7<0.001
Dyspnoea15642.96.02.03.02.067.844.336.8<0.001
Nausea8723.95.03.02.02.088.469.542.0<0.001
Anorexia26272.06.02.05.02.023.712.646.4NS
Asthenia28478.07.02.06.02.019.512.327.3NS
Insomnia18149.76.02.03.02.077.152.851.5<0.001
Anxiety16344.86,.02.04.02.058.830.625.0<0.001
Sadness12634.66.02.04.02.044.725.946.2<0.001
  • *Percentage of patients who, having NRS≥4 at basal visit, had NRS≤4 at follow-up visit.

  • †Mean percentage reduction between NRS values at basal visit and follow-up visit 48–72 h later.

  • ‡Comparison of mean and percentage reduction of NRS between basal visit and follow-up visit.

  • NRS, Numeric Rating Scale.